SCHEMBL6477435

SCHEMBL6477435

CON(C)C(=O)c1csc(N(C(=O)c2ccccc2Cl)c2ccc(C)c(C)c2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.40
GPBAR1 Q8TDU6 3/20 0.39
POLB P06746 2/20 0.36
LMNA P02545 2/20 0.35
DHODH Q02127 4/20 0.35
TP53 P04637 1/20 0.34
ALDH1A1 P00352 3/20 0.34
HTT P42858 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
GAA P10253 1/20 0.34
TSHR P16473 1/20 0.34
BCHE P06276 1/20 0.34
MAPT P10636 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
S1PR1 P21453 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5038951 0.88 KDM4E (0.43) KDM4EGPBAR1POLBLMNADHODH
SCHEMBL5032680 0.88 CES2 (0.41) KDM4EPOLBLMNAALDH1A1SMN1; SMN2
SCHEMBL6477431 0.83 KDM4E (0.38) KDM4EPOLBLMNADHODHTP53
SCHEMBL5034786 0.80 CYP3A4 (0.44) KDM4EALDH1A1RAB9AMAPTKMT2A
SCHEMBL5032643 0.77 FLT1 (0.38) POLBLMNATP53ALDH1A1RAB9A
SCHEMBL5032563 0.77 ALDH1A1 (0.47) KDM4EPOLBLMNAALDH1A1SMN1; SMN2
SCHEMBL5032520 0.75 LMNA (0.47) KDM4EPOLBLMNAALDH1A1HTT
SCHEMBL5032679 0.75 LMNA (0.47) KDM4ELMNADHODHTP53ALDH1A1
SCHEMBL5034815 0.74 KDM4E (0.43) KDM4EGPBAR1POLBDHODHTP53
SCHEMBL5035190 0.73 MAPT (0.49) KDM4ELMNADHODHALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050153962-A1 Thiazole derivatives HOFFMANN-LA ROCHE INC. 2005-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050153962-A1 Thiazole derivatives CNR1, CNR2, GPR119 KDM4E 3200/4885GPBAR1 49/4885POLB 4797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.